Non-Invasive Detection of Tumors by Volatile Organic Compounds in Urine

Area of Science:

• Biochemistry
• Biotechnology
• Oncology

Background:

• Cancer remains a leading cause of mortality, often becoming intractable when diagnosed at later stages.
• Current blood biomarker tests aid in cancer detection, but enhanced accuracy is needed for early-stage diagnosis.
• Novel diagnostic approaches are essential to improve patient survival rates through timely intervention.

Purpose of the Study:

• To review recent advancements in cancer biomarker detection.
• To highlight the potential of volatile organic compounds (VOCs) in urine as cancer biomarkers.
• To explore the application of olfactory receptors in living organisms for cancer diagnosis.

Main Methods:

• Review of current scientific literature on cancer biomarker detection.
• Analysis of studies focusing on volatile organic compounds (VOCs) in human urine.
• Investigation into the use of biological olfactory systems for detecting cancer-specific odors.

Main Results:

• Urinary samples from cancer patients exhibit diverse VOC profiles, with ongoing efforts to identify cancer-specific compounds.
• The olfactory sense in organisms demonstrates an ability to differentiate cancer-associated odors.
• Emerging research suggests potential for novel cancer biomarker candidates and innovative diagnostic methodologies.

Conclusions:

• Volatile organic compounds (VOCs) in urine represent a promising avenue for non-invasive cancer biomarker discovery.
• Olfactory receptor-based detection systems offer a novel approach for early cancer diagnosis.
• Further research into these areas could lead to significantly improved cancer detection rates and patient outcomes.